Literature DB >> 33666055

Optimal biologic dosing in management of obese patients with psoriasis.

Shekhar Neema1, Vikas Pathania1, Niranjan Pudasaini1, Radhakrishnan Subramaniyan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33666055     DOI： 10.25259/IJDVL_241_20

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  4 in total

Review 1.  Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation.

Authors:  Samuel Bremmer; Abby S Van Voorhees; Sylvia Hsu; Neil J Korman; Mark G Lebwohl; Melodie Young; Bruce F Bebo; Andrew Blauvelt
Journal:  J Am Acad Dermatol       Date:  2010-08-07       Impact factor: 11.527

2.  Psoriasis in India: prevalence and pattern.

Authors:  Sunil Dogra; Savita Yadav
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 Nov-Dec       Impact factor: 2.545

3.  Prevalence of cardiovascular risk factors in patients with psoriasis.

Authors:  Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2006-09-25       Impact factor: 11.527

4.  Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis.

Authors:  Andreas Pinter; Sascha Gerdes; Charis Papavassilis; Maximilian Reinhardt
Journal:  J Dermatolog Treat       Date:  2019-07-16       Impact factor: 3.359
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.